-
November 09, 2026
A Federal Circuit judge on Monday appeared perplexed by medical aesthetics provider Medytox Inc.'s position that the U.S. International Trade Commission wrongly rejected its claim that a rival stole its anti-wrinkle technology, saying Medytox's argument "has nothing to do" with the ruling.
-
November 09, 2026
The Ninth Circuit has set aside a judgment directing Research Development Foundation to pay royalties to Pacira Pharmaceuticals Inc. in a contract dispute involving the anesthetic Exparel, further remanding the case for a recalculation of prejudgment interest.
-
November 09, 2026
The attorney general of Ohio is seeking to amend its complaint accusing Express Scripts and several related entities of conspiring to raise prescription drug prices.
-
November 09, 2026
The U.S. Food and Drug Administration on Monday said it is requiring new warnings on GLP-1 medications, the group of blockbuster drugs prescribed for diabetes and weight loss, for a serious, rare condition that can cause sudden and possibly permanent vision loss in one eye.
-
November 09, 2026
Pharmaceutical company Compass Pathways announced Monday that it had submitted to the U.S. Food and Drug Administration a new drug application to treat treatment-resistant depression with psilocybin, the primary compound in psychoactive mushrooms.
-
November 09, 2026
Teva Pharmaceuticals has told a California federal court there is plenty of evidence for a jury to find that Corcept Therapeutics blocked generic competition for its cortisol disorder treatment Korlym by using an exclusive distribution deal with a specialty pharmacy.
-
November 09, 2026
Researchers on Monday challenged the impending phase-out of an office of the National Science Foundation that funds 64% of U.S. research in the social sciences, calling the move to eliminate funding illegal and devastating for their fields.
-
November 09, 2026
The Delaware Chancery Court last week cleared the way for Cloudflare Inc. to seek immediate review of an injunction blocking a stock restructuring designed to preserve its founders' control, while setting a January hearing in a similar dispute over Meta Platforms Inc.'s plan to create nonvoting shares.
-
November 09, 2026
The Seventh Circuit refused to reopen a suit alleging an Illinois county hospital fired a pharmacy technician for requesting a religious exemption from the COVID-19 vaccine, saying it was bound by a recent ruling nixing a similar case.
-
November 09, 2026
The U.S. Supreme Court on Monday declined to hear a real estate developer's case against the city of Pontiac, Michigan, alleging municipal officials violated constitutional rights by delaying approvals of a proposed cannabis operation until it was no longer viable.
-
November 09, 2026
The U.S. Supreme Court on Monday invited the U.S. solicitor general to opine on a lawsuit accusing pharmaceutical companies of aiding a Hezbollah-linked militia's terrorist activities in Iraq, after the D.C. Circuit held the plaintiffs adequately alleged that the companies' participation was conscious and voluntary.
-
November 09, 2026
The U.S. Supreme Court on Monday passed on reviewing a Second Circuit decision that refused to add some $66 million to a $16.6 million arbitral award issued to Acorda Therapeutics in a multiple sclerosis drug dispute, rejecting a petition that sought clarity on when an arbitrator "manifestly disregards" the law.
-
November 09, 2026
The U.S. Supreme Court on Monday declined to review a dispute over rights to healthcare software for a U.S. Army veterinary records system, after the Federal Circuit held a defense subcontractor failed to present a valid contract claim.
-
November 06, 2026
A Florida federal judge denied a bid by a German mosquito-bite patch maker to compel arbitration of a dispute over a license and distribution agreement for the products, ruling that the company's "halfhearted" conferral attempt with opposing counsel violated local rules.
-
November 06, 2026
A California federal court granted final approval to a $45 million settlement resolving proposed class action allegations that digital healthcare company iRhythm Technologies inflated stock prices with misrepresentations about its heart-event monitoring device.
-
November 06, 2026
GlaxoSmithKline and Moderna dismissed two Delaware federal patent suits Friday over Moderna's COVID-19 and respiratory syncytial virus vaccines, following a broader settlement in which the companies agreed to license patents to each other.
-
November 06, 2026
A Connecticut federal judge has granted final approval to a $29.6 million settlement between dozens of states and Glenmark Pharmaceuticals that resolves claims accusing the company of conspiring with competitors to drive up drug prices.
-
November 06, 2026
A Massachusetts jury said Friday that Johnson & Johnson owes $1.9 million for causing the mesothelioma, but not the death, of a former talcum powder user who also had a heart condition.
-
November 06, 2026
Medical device giant Medtronic Inc. is unlawfully monopolizing the market for a type of medical stapler by blocking competitive product trials and using exclusionary bundling tactics in its deals with hospital customers, according to a rival's complaint in Massachusetts federal court.
-
November 06, 2026
An intellectual property attorney has entered a settlement to resolve his False Claims Act suit against the pharmaceutical company Bausch alleging it fraudulently obtained a patent to block the production of a generic ulcerative colitis medication, Apriso.
-
November 06, 2026
In this week's Taxation With Representation, Marvell Technology buys data center optics maker Lumentum, defense technology company Shield acquires radar company Echodyne, and CVS Health plans to split into two independent, publicly traded companies.
-
November 05, 2026
Johnson & Johnson should pay $60 million for the death of a woman who developed mesothelioma alongside her heart problems after using talc products allegedly contaminated with asbestos, counsel for her family told a Massachusetts state jury during closing arguments Thursday.
-
November 05, 2026
The Federal Circuit on Thursday took a critical look at a lower court's decision concluding that Moderna had to face Arbutus' infringement claims over its COVID-19 vaccines, with one judge repeatedly asking why Moderna's vaccine efforts weren't "for the government" within the meaning of a statutory shield for contractors.
-
November 05, 2026
Cannabinoid life sciences and pharmaceutical company Brains Bioceutical Corp. on Thursday unveiled plans to go public by merging with special purpose acquisition company Armada Acquisition Corp. III in a deal that values it at roughly $750 million and that was built by five law firms.
-
November 05, 2026
A New Jersey bankruptcy judge said Thursday he will need to see more evidence to resolve an "ambiguity" over whether class action privacy claims against genetic testing company Invitae Corp. belong in his court.